Akt Inhibitor

Details for Product No. ABIN412306
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Application
Functional Studies (Func), Cell Culture (CC), Blocking Antibody (Inhibition)
Pubmed 2 references available
Quantity 1 mg
Options
Shipping to United States (Change)
Availability Discontinued
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Catalog No. ABIN412306
159.50 $
Plus shipping costs $45.00
Add to Basket

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Characteristics Potent inhibitor of Akt (PKB) (IC50 = 2 µM). Weak inhibitor of phosphatidylinositol 3-kinase (PI3-K) (IC50 = 83 µM). Has been shown to inhibit the growth of the following cancer cell lines: HeLa (IC50 = 2.5 µM), HT-29 (IC50 = 10 µM), MCF-7 (IC50 = 1.2 µM), and PC-3 (IC50 = 2.0 µM).
Purity 98,00 %
Molecular Weight 578.8 Da
Restrictions For Research Use only
Format Solid
Reconstitution Solubility: Soluble in DMSO
Handling Advice Protect from air and moisture.
Storage -20 °C
Expiry Date 12 months
Supplier Images
Akt Inhibitor Akt Inhibitor
Product cited in: Fan, Li, Levy et al.: "Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 178, Issue 10, pp. 6573-80, 2007 (PubMed).

Xiang, Yin, Li et al.: "Hemorrhagic shock activates lung endothelial reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase via neutrophil NADPH oxidase." in: American journal of respiratory cell and molecular biology, Vol. 44, Issue 3, pp. 333-40, 2011 (PubMed).

Validation Images
back to top